Dr. Meghan Claye Riddle, MD

Dr. Riddle practices at Kent Hospital in Warwick, Rhode Island, part of Care New England Health System.

Dr. Riddle's NPI, 1760773683, was assigned on April 26, 2011. Dr. Riddle graduated from University of Texas Medical School at San Antonio in 2011. Dr. Riddle holds Rhode Island license MD17728.

Dr. Riddle's primary practice is Kent Hospital, at 455 Toll Gate Rd, Warwick, RI 02886 in Kent County. The practice phone is (401) 737-7010.

Dr. Riddle's primary practice is Kent Hospital in Warwick, Rhode Island, part of Care New England Health System. The medical group on file is Care New England Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riddle practices. Vendor and product names are available with a free account.

Geriatric psychiatry is Dr. Riddle's primary specialty in the NPI Registry, under taxonomy code 2084P0805X. Dmand AI has Dr. Riddle's licenses on file in 3 states: Rhode Island, Kentucky and Tennessee.

CMS data shows 25 Medicare services from Dr. Riddle across 1 procedure code in 2024, all of them office visits, for 15 Medicare patients. Medicare paid $1,611 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Dr. Riddle in 2024. The largest group is under 65, with 0 patients. 75% of them have depression, and 75% have high cholesterol. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Riddle's median patient age at 77, with 67% women.

In 2024, Dr. Riddle wrote 549 Medicare Part D claims for 38 patients. 99% of them were for generic drugs. CMS names the drug for 467 of them, across 17 drugs with 11 or more claims each, at $9,496 in total drug cost. In 2023, CMS named 540 claims across 21 drugs.

Dr. Riddle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Riddle as offering telehealth.

Dmand AI links 9 papers to Dr. Riddle, published from 2014 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Alzheimer Disease, Depressive Disorder, Major and Neuropsychological Tests. Dr. Riddle has published most often in Alzheimers Dement. Dr. Riddle's most frequent co-authors are Paul Stephen Aisen, Gregory Scott Day, MD and Bradford Clark Dickerson, MD.

Dmand AI links Dr. Riddle to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Alzheimer Disease, Cognitive Dysfunction and Pick Disease of the Brain. University of Southern California sponsors the most, 2. Open Payments lists research payments to Dr. Riddle that name 1 trial.

CMS Open Payments shows 1 general payment to Dr. Riddle from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $80. It also lists 1 research payment totaling $511 in 2023, naming 1 clinical trial.

Dr. Riddle graduated from University of Texas Medical School at San Antonio in 2011.